203192-01-2
203192-01-2 結(jié)構(gòu)式
基本信息
1-[[4-[4-[4-[[4-(dimethylamino)pyridin-1-ium-1-yl]methyl]phenyl]butyl]phenyl]methyl]-N,N-dimethylpyridin-1-ium-4-amine
物理化學(xué)性質(zhì)
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2026/06/05 | HY-108431 | 化合物MN58B MN58b | 203192-01-2 | 1mg | 3500元 |
| 2023/01/06 | S0998 | 化合物MN58B MN58b | 203192-01-2 | 1mg | 6036.03元 |
常見問題列表
Choline kinase α (CHKα)
The
IC
50
s of MN58b for parental and Gemcitabine-resistant Suit2 007 cells are 3.14 μM and 0.77 μM, respectively.
MN58b (1-5 μM; 72 hours; SK-PC-1, Suit2 008, IMIM-PC2, and RWP-1 cells) has a marked effect on colony formation at 1 μM, and growth is completely abolished at 5 μM in all the cell lines.
MN58b ((1-10 μM; 24-48 hours; SK-PC-1, Suit2 008, IMIM-PC2, and RWP-1 cells) induces apoptosis and this response correlates with CHKα expression.
Cell Viability Assay
| Cell Line: | SK-PC-1, Suit2 008, IMIM-PC2, and RWP-1 cells |
| Concentration: | 1 μM, 5 μM |
| Incubation Time: | 72 hours |
| Result: | Inhibited cells growth. |
Apoptosis Analysis
| Cell Line: | SK-PC-1, Suit2 008, IMIM-PC2, and RWP-1 cells |
| Concentration: | 1 μM, 2 μM, 5 μM, 10 μM |
| Incubation Time: | 24 and 48 hours |
| Result: | Induced cell apoptosis. |
MN58b (4 mg/kg; intraperitoneal injection; once a day; for 5 days; MF-1 nude mice) treatment significantly decreases phosphomonoesters in both HT29 and MDA-MB-231 xenografts. Phosphocholine levels are found to correlate with choline kinase activities.
| Animal Model: | MF-1 nude mice with HT29 or MDA-MB-231 cells |
| Dosage: | 4 mg/kg |
| Administration: | Intraperitoneal injection; once a day; for 5 days |
| Result: | Phosphomonoesters decreased significantly. |